[1]
T. Zupanc, J. Krajačič, B. Krajačič, O. Zupanc, and M. Bunc, “Inclisiran, a Potent Lipid Lowering Treatment for Reaching LDL Goals on Top of Statins and Ezetimibe: A Single User Experiences”, SEE J Cardiol, vol. 5, pp. 30–33, Nov. 2024.